Healthcare Stocks Show Deeply Divided Investor Sentiment

According to data from late September 2026, investor sentiment in the healthcare sector is sharply divided. The State Street Health Care Select Sector SPDR ETF (XLV) shows a snapshot of this contrast. Strong bearish bets remain heavily concentrated in high-volatility clinical-stage biotechnology and health equipment names like Recursion Pharmaceuticals (RXRX) and Strive (ASST).

These companies are among the most shorted mid- to mega-cap healthcare stocks, with RXRX sporting a significant 31.3% short interest ratio at the end of September. In comparison, some blue-chip pharmaceuticals like Johnson & Johnson (JNJ) and AbbVie (ABBV) have relatively low short interest ratios.

The data suggests that investors are taking contrasting views on the healthcare sector's prospects. While some companies may be deemed too risky or uncertain for investors to hold, others are seen as more stable and attractive.